Newscast – Page 52 – media

Increased Bilirubin can Reduce Cardiovascular Risk

This research study was conducted on 100,000 participants including both HIV and non-HIV patients, aged around 48 years on an average. The results were published in the Journal of the American Heart Association where the participants with higher levels of bilirubin had 76% risk for cardiovascular diseases as same as the group with the lower bilirubin levels.
- Source: India Times
- 666
- July 5, 2018
heart disease Researches
Polio Virus Treats Brain Tumours

In a major breakthrough in the medical field, one of the world’s most dreadful viruses could possibly treat deadly brain tumors (glioblastoma). The survival chance turned out to be better than expected especially for patients who were administered the genetically modified poliovirus.
- Source: India Times
- 753
- July 5, 2018
brain tumor polio Researches
Philips Launches First eICU in Japan

Telemedicine services are gaining entry into Japanese hospitals. Royal Philips recently announced its deal with Showa University in Japan in order to launch the first telemedicine intensive care program (eICU) at Showa Koto Toyosu Hospital and Showa University Hospital. This program will reduce mortality rates and increase savings as well as case volume.
- Source: BusinessInsider
- 780
- July 5, 2018
Company Insight Japan Phillips Telemedicine
WHO Reports Improvement in Hepatitis-C Cure Annually

A report was issued by the World Health Organization (WHO) recently that the number of people receiving hepatitis C cures was increased from 1 million in 2015 to 1.5 million in 2016. Previously, only a small number of countries took part in hepatitis C treatments.
- Source: WHO
- 984
- July 5, 2018
hepatitis C Market Views WHO
Johnson & Johnson Wins Once Again in Talc Powder Case

Johnson & Johnson has once again won in its appeals campaign against talcum powder verdicts. Last year, the company had secured two reversals. In this year, the Missouri Court of Appeals reversed another verdict in Gloria Ristesund’s case worth $55 million, where the court lacked jurisdiction.
- Source: FiercePharma
- 767
- July 5, 2018
Company Insight Johnson & Johnson lawsuit
Appthority Reports Security Threat Behind Health Apps & Records

Appthority, the mobile app security firm revealed that a security threat affecting more than 3,000 mobile apps exposes around 4 million protected health records such as prescription details and sensitive chat messages.
- Source: MobiHealthNews
- 760
- July 4, 2018
Company Insight cybersecurity digital health
FDA Approves Pulmonx’s Zephyr Device to Treat Emphysema

The premarket approval of Pulmonx’s Zephyr Endobronchial Valve to treat severe emphysema has green-lighted by the FDA. Zephyr is a pencil eraser-sized device delivered directly to the lung in a minimally invasive procedure. After the successful delivery, the device stops air from entering diseased parts of the lung during breathing. This mechanism prevents the air from getting trapped by damaged alveoli and stops the breathing difficulties.
- Source: FierceBiotech
- 895
- July 4, 2018
emphysema FDA medtech New Approvals
Screening of Pancreatic Cancer via Smartphone App

This app uses a smartphone camera, computer vision algorithms and machine learning tools to assess bilirubin levels in the white part of the eye named sclera since jaundice is considered as one of the earliest symptoms of pancreatic cancer. The eyes and the skin become yellow colored due to the accumulation of bilirubin in the blood caused by jaundice.
- Source: mHealthSpot
- 745
- July 4, 2018
digital health mHealth pancreatic cancer Researches
Invention of 3-D Bioprint Cornea

One such a research team is from Newcastle University where they have invented a 3D bioprint cornea, in order to control and focus the entry of light into the eye. By using a simple 3D bio-printer, the team united healthy corneal stem cells using hydration and alginate to produce ’bio-ink’. It is a simple solution used to replicate a human embryo form within 10 minutes.
- Source: Biotecnika
- 640
- July 4, 2018
3D printing bioprint Researches
$20 Blood Test to Detect Hepatitis B

Hepatitis is considered as the seventh leading cause of death throughout the world, where half of the deaths occur due to hepatitis B viral infection. Early cost-effective diagnosis could help in treating the affected patients without any delay.
- Source: MedicalXpress
- 739
- July 4, 2018
blood test hepatitis B Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.